Print

Video: Mass Vaccination in a Pandemic: Benefits versus Risks: Dr. Geert Vanden Bossche
By Dr. Geert Vanden Bossche and Dr. Philip McMillan
Global Research, March 17, 2021
Artsen Voor Vrijheid 9 March 2021
Url of this article:
https://www.globalresearch.ca/video-mass-vaccination-pandemic-benefits-versus-risks/5739764

All Global Research articles can be read in 27 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).

***

Geert Vanden Bossche PhD, is an internationally recognised vaccine developer having worked as the head of the Vaccine Development Office at the German Centre for Infection Research.

Coordinated Global Alliance for Vaccines and Immunisation’s Ebola Vaccine Program and contributed to the implementation of an integrated vaccine work plan in collaboration with Global Health Partners (WHO, Bill & Melinda Gates Foundation, CDC, UNICEF), regulators (FDA) and vaccine manufacturers to enable timely deployment or stockpiling of Ebola vaccine candidates.

Highlighting the principle of using a prophylactic vaccine in the midst of a pandemic. Likely to create more more viral variants in the process.

Sharing his perspective on mass vaccination in COVID-19.

*

Note to readers: please click the share buttons above or below. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article.